Siegel RL, Giaquinto AN, Jemal A. CA: a cancer journal for clinicians. Cancer statistics. 2024;74(1):12–49.
Gbolahan O, et al. Time to treatment initiation and its impact on real-world survival in metastatic colorectal cancer and pancreatic cancer. Cancer Med. 2023;12(3):3488–98.
Article CAS PubMed Google Scholar
Li F, et al. Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches. Front Pharmacol. 2023;14:1165666.
Article CAS PubMed PubMed Central Google Scholar
Fuentes JDB, et al. Global stage distribution of breast cancer at diagnosis: a systematic review and meta-analysis. JAMA Oncol. 2024. https://doi.org/10.1001/jamaoncol.2023.4837.
Larribère L, Martens UM. Advantages and challenges of using ctDNA NGS to assess the presence of minimal residual disease (MRD) in solid tumors. Cancers. 2021;13(22):5698.
Article PubMed PubMed Central Google Scholar
Appierto V, et al. How to study and overcome tumor heterogeneity with circulating biomarkers: the breast cancer case. In: Seminars in cancer biology. Elsevier; 2017.
Esposito A, et al. Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies. Pharmacol Ther. 2016;157:120–4.
Article CAS PubMed Google Scholar
Li M, et al. Liquid biopsy at the frontier in renal cell carcinoma: recent analysis of techniques and clinical application. Mol Cancer. 2023;22(1):1–51.
Visal TH, et al. Circulating tumour cells in the-omics era: how far are we from achieving the ‘singularity’? Br J Cancer. 2022;127(2):173–84.
Article CAS PubMed PubMed Central Google Scholar
Hartkopf AD, et al. Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer. Anticancer Res. 2011;31(3):979–84.
Xia W, et al. In vivo coinstantaneous identification of hepatocellular carcinoma circulating tumor cells by dual-targeting magnetic-fluorescent nanobeads. Nano Lett. 2020;21(1):634–41.
Szczerba BM, et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature. 2019;566(7745):553–7.
Article CAS PubMed Google Scholar
Kasimir-Bauer S, et al. In early breast cancer, the ratios of neutrophils, platelets and monocytes to lymphocytes significantly correlate with the presence of subsets of circulating tumor cells but not with disseminated tumor cells. Cancers. 2022;14(14):3299.
Article CAS PubMed PubMed Central Google Scholar
Aceto N, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158(5):1110–22.
Article CAS PubMed PubMed Central Google Scholar
Cheung KJ, et al. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell. 2013;155(7):1639–51.
Article CAS PubMed PubMed Central Google Scholar
Cheung KJ, et al. Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters. Proc Natl Acad Sci. 2016;113(7):E854–63.
Article CAS PubMed PubMed Central Google Scholar
Gkountela, S., et al., Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding. Cell, 2019. 176(1): p. 98–112. e14.
Wei R-R, et al. CTC clusters induced by heparanase enhance breast cancer metastasis. Acta Pharmacol Sin. 2018;39(8):1326–37.
Article CAS PubMed PubMed Central Google Scholar
Donato C, et al. Hypoxia triggers the intravasation of clustered circulating tumor cells. Cell Rep. 2020;32(10):108105.
Article CAS PubMed PubMed Central Google Scholar
Francescangeli F, et al. Sequential isolation and characterization of single CTCs and large CTC Clusters in metastatic colorectal cancer patients. Cancers. 2021;13(24):6362.
Article CAS PubMed PubMed Central Google Scholar
Amintas S, et al. Circulating tumor cell clusters: united we stand divided we fall. Int J Mol Sci. 2020;21(7):2653.
Article CAS PubMed PubMed Central Google Scholar
Kapeleris J, et al. Cancer stemness contributes to cluster formation of colon cancer cells and high metastatic potentials. Clin Exp Pharmacol Physiol. 2020;47(5):838–47.
Article CAS PubMed Google Scholar
Strell C, Entschladen F. Extravasation of leukocytes in comparison to tumor cells. Cell Commun Signal. 2008;6:1–13.
Au SH, et al. Clusters of circulating tumor cells traverse capillary-sized vessels. Proc Natl Acad Sci. 2016;113(18):4947–52.
Article CAS PubMed PubMed Central Google Scholar
Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576–90.
Article CAS PubMed PubMed Central Google Scholar
Ward Y, et al. Platelets promote metastasis via binding tumor CD97 leading to bidirectional signaling that coordinates transendothelial migration. Cell Rep. 2018;23(3):808–22.
Article CAS PubMed PubMed Central Google Scholar
Xiao L, et al. Effects of flowing RBCs on adhesion of a circulating tumor cell in microvessels. Biomech Model Mechanobiol. 2017;16:597–610.
Article CAS PubMed Google Scholar
Helwa R, et al. Tumor cells interact with red blood cells via galectin-4-a short report. Cell Oncol. 2017;40:401–9.
de Sousa e Melo F, et al. A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer. Nature. 2017;543(7647):676–80.
Kasimir-Bauer S, et al. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res. 2012;14:1–9.
Li W, et al. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis. Sci Rep. 2017;7(1):13856.
Article PubMed PubMed Central Google Scholar
Lianidou E, Hoon D. Circulating tumor cells and circulating tumor DNA. In: Principles and applications of molecular diagnostics. Elsevier; 2018. p. 235–81.
Adorno-Cruz V, et al. Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance. Can Res. 2015;75(6):924–9.
Delle Cave D, et al. Nodal-induced L1CAM/CXCR4 subpopulation sustains tumor growth and metastasis in colorectal cancer derived organoids. Theranostics. 2021;11(12):5686.
Guan G, et al. The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells. Cancer Lett. 2015;357(1):254–64.
留言 (0)